Adalimumab and Infliximab Are Equally Effective for Crohn's Disease in Patients Not Previously Treated With Anti–Tumor Necrosis Factor-α Agents
Titel:
Adalimumab and Infliximab Are Equally Effective for Crohn's Disease in Patients Not Previously Treated With Anti–Tumor Necrosis Factor-α Agents
Auteur:
Kestens, Christine van Oijen, Martijn G.H. Mulder, Charlotte L.J. van Bodegraven, Ad A. Dijkstra, Gerard de Jong, Dirk Ponsioen, Cyriel van Tuyl, Bas A.C. Siersema, Peter D. Fidder, Herma H. Oldenburg, Bas